Hyperphosphorylation of RNA polymerase II and reduced neuronal RNA levels precede neurofibrillary tangles in Alzheimer disease

Jacob W. Husseman, Janice L. Hallows, David B. Bregman, James B. Leverenz, David Nochlin, Lee-Way Jin, Inez Vincent

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Affected neurons of Alzheimer disease (AD) brain are distinguished by the presence of the cell cycle cdc2 kinase and mitotic phosphoepitopes. A significant body of previous data has documented a decrease in neuronal RNA levels and nucleolar volume in AD brain. Here we present evidence that integrates these seemingly distinct findings and offers an explanation for the degenerative outcome of the disease. During mitosis cdc2 phosphorylates and inhibits the major transcriptional regulator RNA polymerase II (RNAP II). We therefore investigated cdc2 phosphorylation of RNAP II in AD brain. Using the H5 and H14 monoclonal antibodies specific for the cdc2-phosphorylated sites in RNAP II, we found that the polymerase is highly phosphorylated in AD. Moreover, RNAP II in AD translocates from its normally nuclear compartment to the cytoplasm of affected neurons, where it colocalizes with cdc2. These M phase-like changes in RNAP II correlate with decreased levels of poly-A RNA in affected neurons. Significantly, they precede tau phosphorylation and neurofibrillary tangle formation. Our data support the hypothesis that inappropriate activation of the cell cycle cdc2 kinase in differentiated neurons contributes to neuronal dysfunction and degeneration in part by inhibiting RNAP II and cellular processes dependent on transcription.

Original languageEnglish (US)
Pages (from-to)1219-1232
Number of pages14
JournalJournal of Neuropathology and Experimental Neurology
Volume60
Issue number12
StatePublished - 2001
Externally publishedYes

Fingerprint

Neurofibrillary Tangles
RNA Polymerase II
Alzheimer Disease
RNA
Neurons
Cell Cycle
Brain
Phosphotransferases
Phosphorylation
Mitosis
Cell Division
Cytoplasm
Monoclonal Antibodies
Messenger RNA

Keywords

  • Alzheimer disease
  • Cdc2
  • Cell cycle
  • Neurofibrillary tangles
  • RNA polymerase II
  • Tau phosphorylation
  • Transcription

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Neuroscience(all)

Cite this

Hyperphosphorylation of RNA polymerase II and reduced neuronal RNA levels precede neurofibrillary tangles in Alzheimer disease. / Husseman, Jacob W.; Hallows, Janice L.; Bregman, David B.; Leverenz, James B.; Nochlin, David; Jin, Lee-Way; Vincent, Inez.

In: Journal of Neuropathology and Experimental Neurology, Vol. 60, No. 12, 2001, p. 1219-1232.

Research output: Contribution to journalArticle

Husseman, Jacob W. ; Hallows, Janice L. ; Bregman, David B. ; Leverenz, James B. ; Nochlin, David ; Jin, Lee-Way ; Vincent, Inez. / Hyperphosphorylation of RNA polymerase II and reduced neuronal RNA levels precede neurofibrillary tangles in Alzheimer disease. In: Journal of Neuropathology and Experimental Neurology. 2001 ; Vol. 60, No. 12. pp. 1219-1232.
@article{9daf06049bf44b1cb5ec0227ec2d2139,
title = "Hyperphosphorylation of RNA polymerase II and reduced neuronal RNA levels precede neurofibrillary tangles in Alzheimer disease",
abstract = "Affected neurons of Alzheimer disease (AD) brain are distinguished by the presence of the cell cycle cdc2 kinase and mitotic phosphoepitopes. A significant body of previous data has documented a decrease in neuronal RNA levels and nucleolar volume in AD brain. Here we present evidence that integrates these seemingly distinct findings and offers an explanation for the degenerative outcome of the disease. During mitosis cdc2 phosphorylates and inhibits the major transcriptional regulator RNA polymerase II (RNAP II). We therefore investigated cdc2 phosphorylation of RNAP II in AD brain. Using the H5 and H14 monoclonal antibodies specific for the cdc2-phosphorylated sites in RNAP II, we found that the polymerase is highly phosphorylated in AD. Moreover, RNAP II in AD translocates from its normally nuclear compartment to the cytoplasm of affected neurons, where it colocalizes with cdc2. These M phase-like changes in RNAP II correlate with decreased levels of poly-A RNA in affected neurons. Significantly, they precede tau phosphorylation and neurofibrillary tangle formation. Our data support the hypothesis that inappropriate activation of the cell cycle cdc2 kinase in differentiated neurons contributes to neuronal dysfunction and degeneration in part by inhibiting RNAP II and cellular processes dependent on transcription.",
keywords = "Alzheimer disease, Cdc2, Cell cycle, Neurofibrillary tangles, RNA polymerase II, Tau phosphorylation, Transcription",
author = "Husseman, {Jacob W.} and Hallows, {Janice L.} and Bregman, {David B.} and Leverenz, {James B.} and David Nochlin and Lee-Way Jin and Inez Vincent",
year = "2001",
language = "English (US)",
volume = "60",
pages = "1219--1232",
journal = "American Journal of Psychotherapy",
issn = "0002-9564",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - Hyperphosphorylation of RNA polymerase II and reduced neuronal RNA levels precede neurofibrillary tangles in Alzheimer disease

AU - Husseman, Jacob W.

AU - Hallows, Janice L.

AU - Bregman, David B.

AU - Leverenz, James B.

AU - Nochlin, David

AU - Jin, Lee-Way

AU - Vincent, Inez

PY - 2001

Y1 - 2001

N2 - Affected neurons of Alzheimer disease (AD) brain are distinguished by the presence of the cell cycle cdc2 kinase and mitotic phosphoepitopes. A significant body of previous data has documented a decrease in neuronal RNA levels and nucleolar volume in AD brain. Here we present evidence that integrates these seemingly distinct findings and offers an explanation for the degenerative outcome of the disease. During mitosis cdc2 phosphorylates and inhibits the major transcriptional regulator RNA polymerase II (RNAP II). We therefore investigated cdc2 phosphorylation of RNAP II in AD brain. Using the H5 and H14 monoclonal antibodies specific for the cdc2-phosphorylated sites in RNAP II, we found that the polymerase is highly phosphorylated in AD. Moreover, RNAP II in AD translocates from its normally nuclear compartment to the cytoplasm of affected neurons, where it colocalizes with cdc2. These M phase-like changes in RNAP II correlate with decreased levels of poly-A RNA in affected neurons. Significantly, they precede tau phosphorylation and neurofibrillary tangle formation. Our data support the hypothesis that inappropriate activation of the cell cycle cdc2 kinase in differentiated neurons contributes to neuronal dysfunction and degeneration in part by inhibiting RNAP II and cellular processes dependent on transcription.

AB - Affected neurons of Alzheimer disease (AD) brain are distinguished by the presence of the cell cycle cdc2 kinase and mitotic phosphoepitopes. A significant body of previous data has documented a decrease in neuronal RNA levels and nucleolar volume in AD brain. Here we present evidence that integrates these seemingly distinct findings and offers an explanation for the degenerative outcome of the disease. During mitosis cdc2 phosphorylates and inhibits the major transcriptional regulator RNA polymerase II (RNAP II). We therefore investigated cdc2 phosphorylation of RNAP II in AD brain. Using the H5 and H14 monoclonal antibodies specific for the cdc2-phosphorylated sites in RNAP II, we found that the polymerase is highly phosphorylated in AD. Moreover, RNAP II in AD translocates from its normally nuclear compartment to the cytoplasm of affected neurons, where it colocalizes with cdc2. These M phase-like changes in RNAP II correlate with decreased levels of poly-A RNA in affected neurons. Significantly, they precede tau phosphorylation and neurofibrillary tangle formation. Our data support the hypothesis that inappropriate activation of the cell cycle cdc2 kinase in differentiated neurons contributes to neuronal dysfunction and degeneration in part by inhibiting RNAP II and cellular processes dependent on transcription.

KW - Alzheimer disease

KW - Cdc2

KW - Cell cycle

KW - Neurofibrillary tangles

KW - RNA polymerase II

KW - Tau phosphorylation

KW - Transcription

UR - http://www.scopus.com/inward/record.url?scp=0035205666&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035205666&partnerID=8YFLogxK

M3 - Article

C2 - 11764094

AN - SCOPUS:0035205666

VL - 60

SP - 1219

EP - 1232

JO - American Journal of Psychotherapy

JF - American Journal of Psychotherapy

SN - 0002-9564

IS - 12

ER -